ArticleThe oncologist2024

Impact of relative cisplatin dose to skeletal muscle mass on adverse events in patients with head and neck cancer undergoing chemoradiotherapy.

Satoshi Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.